Categories AlphaGraphs, Earnings, Health Care
Sun Pharmaceuticals Industries Ltd Q2FY25; 28% rise in Profits
Sun Pharmaceutical Industries Ltd is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulations and Active Pharma Ingredients (APIs). The company and its subsidiaries has various manufacturing facilities spread across the world with trading and other incidental and related activities extending to global market. It is the largest pharmaceutical company in India.
Financial Results:
Sun Pharmaceuticals Industries Ltd reported Revenues for Q2FY25 of ₹13,264.00 Crores up from ₹12,192.00 Crore year on year, a rise of 11%.
Total Expenses for Q2FY25 of ₹10,047.00 Crores up from ₹9,695.00 Crores year on year, a rise of 3.63%.
Consolidated Net Profit of ₹3,040.00 Crores up 27.7% from ₹2,385.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹12.67, up 27.98% from ₹9.90 in the same quarter of the previous year.
Most Popular
Cochin Shipyard Ltd (COCHINSHIP) Q4 FY22 Earnings Concall Transcript
Cochin Shipyard Limited (NSE:COCHINSHIP) Q4 FY22 Earnings Concall dated May. 26, 2022 Corporate Participants: Madhu S Nair -- Chairman & Managing Director Jose V J -- Director Finance Analysts: Vastupal Shah
All you need to know about Antony Waste Handling Cell in one article
Can you guess the name of the company that was listed during the IPO frenzy in 2020 and is the second largest player in the Indian municipal waste management industry?
Demystifying the Leading Non-Ferrous Recycling Company of India
“Hey, how is the market doing today?” “Oh!, its falling tremendously since morning” I am sure news like these might be a common topic of discussion for you nowadays. Interestingly,